Disease comes with age and, consequently, most medicines are used by the elderly. Elderly patients have characteristics in which they differ substantially from younger patients.
Understanding older patients and the environments in which they use their medicines is, therefore, pivotal for developing suitable medicines. Examples will be given where drug development was not successful enough and suggestions made on what to do to obtain better therapeutic outcomes in elderly patients. The future of successful drug therapy in our aging society depends on finding answers to the needs of these vulnerable patients.
|
|